@builderlibrarian.bsky.social#AskDrMia is sharing tips you may not know when considering infusion medications like #Lecanemab #Donanemab #Leqembi #Kisnula for #dementia. Stream the whole episode wherever you stream your #Podcasts.
youtube.com/shorts/j4D-I...
@builderlibrarian.bsky.socialEver wonder what advice a #geriatrician would give their own family about about infusion medications like #lecanemab #donanemab #leqembi #kisunla for #dementia? #AskDrMia gives her audience the family treatment in this new episode. Stream wherever you listen to podcasts
youtube.com/shorts/WSUOa...
@gmj-georgia.bsky.socialAnti-amyloid monoclonal antibodies are transforming Alzheimer's care, but clinicians now face a new challenge: which patients should continue therap… #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking #Donanemab #Lecanemab #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking…
@builderlibrarian.bsky.socialThis week, the “Ask” in #AskDrMia shines as @askdrmia.bsky.social breaks down new research in anti-amyloid treatments. What #caregivers should know and more wherever you listen to #podcasts. #lecanemab #Leqembi #donanemab #Kisunla #amyloids #dementia #memory
youtube.com/shorts/hA1K8...
@newsen.bsky.socialStudy Reveals Plasma p-Tau217 as a Tracker for Lecanemab Response in Early Alzheimer's #South_Korea #Seoul #Korea_University #Lecanemab #p-Tau217
@gmj-georgia.bsky.socialAnti-amyloid monoclonal antibodies are transforming Alzheimer's care, but clinicians now face a new challenge: which patients should continue therap… #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking #Donanemab #Lecanemab #Alzheimersdisease #AmyloidPETimaging #Clinicaldecisionmaking…